Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications
- PMID: 29982551
- DOI: 10.1210/er.2018-00083
Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications
Erratum in
-
CORRIGENDUM FOR "Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications".Endocr Rev. 2019 Feb 1;40(1):96. doi: 10.1210/er.2018-00278. Endocr Rev. 2019. PMID: 30541072 No abstract available.
Abstract
Children born small for gestational age (SGA), defined as a birth weight and/or length below -2 SD score (SDS), comprise a heterogeneous group. The causes of SGA are multifactorial and include maternal lifestyle and obstetric factors, placental dysfunction, and numerous fetal (epi)genetic abnormalities. Short-term consequences of SGA include increased risks of hypothermia, polycythemia, and hypoglycemia. Although most SGA infants show catch-up growth by 2 years of age, ∼10% remain short. Short children born SGA are amenable to GH treatment, which increases their adult height by on average 1.25 SD. Add-on treatment with a gonadotropin-releasing hormone agonist may be considered in early pubertal children with an expected adult height below -2.5 SDS. A small birth size increases the risk of later neurodevelopmental problems and cardiometabolic diseases. GH treatment does not pose an additional risk.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
